Russell Investments Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-365
| Closed | -$3.39K | – | 3825 |
|
|
2024
Q2 | $3.39K | Buy |
+365
| New | +$3.39K | ﹤0.01% | 3288 |
|
|
2024
Q1 | – | Sell |
-876
| Closed | -$23.4K | – | 3378 |
|
|
2023
Q4 | $23.4K | Sell |
876
-7,285
| -89% | -$195K | ﹤0.01% | 2727 |
|
|
2023
Q3 | $494K | Buy |
8,161
+7,215
| +763% | +$436K | ﹤0.01% | 2230 |
|
|
2023
Q2 | $96.3K | Buy |
946
+910
| +2,528% | +$92.7K | ﹤0.01% | 2610 |
|
|
2023
Q1 | $6.37K | Buy |
+36
| New | +$6.37K | ﹤0.01% | 2929 |
|
|
2022
Q2 | – | Sell |
-915
| Closed | -$398K | – | 2980 |
|
|
2022
Q1 | $398K | Sell |
915
-150
| -14% | -$65.2K | ﹤0.01% | 2294 |
|
|
2021
Q4 | $466K | Sell |
1,065
-349
| -25% | -$153K | ﹤0.01% | 2472 |
|
|
2021
Q3 | $786K | Buy |
1,414
+18
| +1% | +$10K | ﹤0.01% | 2288 |
|
|
2021
Q2 | $716K | Sell |
1,396
-176
| -11% | -$90.3K | ﹤0.01% | 2455 |
|
|
2021
Q1 | $1.23M | Sell |
1,572
-1,016
| -39% | -$794K | ﹤0.01% | 2159 |
|
|
2020
Q4 | $1.41M | Buy |
2,588
+814
| +46% | +$443K | ﹤0.01% | 1942 |
|
|
2020
Q3 | $812K | Buy |
1,774
+1,176
| +197% | +$538K | ﹤0.01% | 2162 |
|
|
2020
Q2 | $367K | Buy |
+598
| New | +$367K | ﹤0.01% | 2502 |
|
|
2020
Q1 | – | Sell |
-168
| Closed | -$97K | – | 3159 |
|
|
2019
Q4 | $97K | Hold |
168
| – | – | ﹤0.01% | 2896 |
|
|
2019
Q3 | $110K | Buy |
+168
| New | +$110K | ﹤0.01% | 2809 |
|
|
2018
Q1 | – | Sell |
-173
| Closed | -$80K | – | 3018 |
|
|
2017
Q4 | $80K | Hold |
173
| – | – | ﹤0.01% | 2817 |
|
|
2017
Q3 | $85K | Sell |
173
-712
| -80% | -$350K | ﹤0.01% | 2798 |
|
|
2017
Q2 | $490K | Sell |
885
-501
| -36% | -$277K | ﹤0.01% | 2417 |
|
|
2017
Q1 | $918K | Buy |
1,386
+190
| +16% | +$126K | ﹤0.01% | 2142 |
|
|
2016
Q4 | $404K | Buy |
+1,196
| New | +$404K | ﹤0.01% | 2537 |
|